Tag Archives: EIHA

Saturday Special | THE EIHA’s POSITION ON HEMP EXTRACTS

EIHA PRESENTATION ON HEMP EXTRACT BY: Lorenza Romanese EIHA Managing Director Daniel Kruse, Board Member Tony Reeves, Advisory Committee 12 March 2019, WG PAFF Committee Who is EIHA and who do they represent: • Originally formed almost 19 years ago; officially founded in 2005. Based in Brussels and Cologne • The only pan-European consortium in the industrial hemp sector •

Read more

WEDNESDAY MARKET REPORT | WORLD HEALTH ORGANISATION REMOVES CANNABIS STIGMA

‘Zelda’ Engages International Cannabis and Cannabinoids Institute for Clinical Trial and Regulatory Expertise.  Zelda Therapeutics Ltd has engaged with the International Cannabis and Cannabinoids Institute (ICCI) to support the Company’s clinical trial programmes in autism, opioid reduction, and insomnia. Zelda Therapeutics Ltd is an Australian-based bio-pharmaceutical company developing a range of cannabinoid-based formulations for the treatment of avariety of medical

Read more